Cephalexin
- Product NDC
- 67877-255
- 11-digit product format
- 678770255
- Labeler code
- 67877
- Product ID
- 67877-255_3e6d72ab-f4ea-4ca6-984d-e6de1b3e7fdf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cephalexin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA090836
- Marketing category
- ANDA
- Marketing start
- 2012-06-04
- Substance
- CEPHALEXIN
- Active strength
- 750 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cephalexin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEPHALEXIN | 750 mg/1 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEPHALEXIN | ACTIVE INGREDIENT | OBN7UDS42Y | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| CEPHALEXIN ANHYDROUS | ACTIVE MOIETY | 5SFF1W6677 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 20 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67877-255 | CEPHALEXIN CAPSULE [ASCEND LABORATORIES, LLC] | 28 | Current NDC, Legacy NDC, 5 package rows | 20220702_4fec8daf-6e09-4153-926f-64709dbdd26c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67877-255-01 | 67877025501 | 100 CAPSULE in 1 BOTTLE (67877-255-01) | 100 capsule | 2012-06-04 | 0000-00-00 | No | No | Current |
| 67877-255-05 | 67877025505 | 500 CAPSULE in 1 BOTTLE (67877-255-05) | 500 capsule | 2012-06-04 | 0000-00-00 | No | No | Current |
| 67877-255-10 | 67877025510 | 1000 CAPSULE in 1 BOTTLE (67877-255-10) | 1000 capsule | 2012-06-04 | 0000-00-00 | No | No | Current |
| 67877-255-20 | 67877025520 | 20 CAPSULE in 1 BOTTLE (67877-255-20) | 20 capsule | 2012-06-04 | 0000-00-00 | No | No | Current |
| 67877-255-23 | 67877025523 | 50 CAPSULE in 1 BOTTLE (67877-255-23) | 50 capsule | 2012-06-04 | 0000-00-00 | No | No | Current |